MICHAEL KRAFCHICK: Open Payments
NPI 1275623506 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 63 payments from 22 companies in 2025. Trend: 2023 $2,478 · 2024 $3,453 · 2025 $1,244
Food & beverage: $1,244
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $195 |
| Axsome Therapeutics, Inc. | 11 | $176 |
| PFIZER INC. | 5 | $106 |
| ABBVIE INC. | 4 | $92 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Exact Sciences Corporation | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
Products named: Auvelity, TRELEGY ELLIPTA, VOQUEZNA, Wegovy, Ozempic, ELIQUIS, UBRELVY, Veozah.
Industry payments across PA — which companies pay providers there.
